Pfizer (PFE)
28.45
-0.36 (1.25%)
Upcoming Events
Latest Headlines
Form 4 PFIZER INC For: Aug 31 Filed by: BOURLA ALBERT
September 1, 2026 5:54 PM - SEC Filing
Form N-PX PFIZER INC For: Jun 30
August 31, 2026 4:04 PM - SEC Filing
Form 3 PFIZER INC For: Aug 17 Filed by: Guegan Cecile
August 28, 2026 2:37 PM - SEC Filing
FDA approves Pfizer-BioNTech XFG-targeted Covid-19 vaccine
August 27, 2026 4:30 PM - StreetInsider
Form 4 PFIZER INC For: Aug 14 Filed by: BOURLA ALBERT
August 17, 2026 6:15 PM - SEC Filing
EMA validates Pfizer and Valneva's Lyme disease vaccine application
August 14, 2026 1:00 AM - StreetInsider
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
August 14, 2026 1:00 AM - StreetInsider
Form 13F-HR PFIZER INC For: Jun 30
August 13, 2026 4:44 PM - SEC Filing
Form 4 PFIZER INC For: Aug 12 Filed by: BOURLA ALBERT
August 12, 2026 4:05 PM - SEC Filing
PFE builds bull case at $26 after earnings beat and insider buys
August 7, 2026 9:42 AM - StreetInsider
Pfizer (PFE) PT Lowered to $29 at Bernstein SocGen Group
August 7, 2026 9:11 AM - StreetInsider
Trump Administration Weighs Order On Autism And Vaccines - Bloomberg
August 6, 2026 4:36 PM - StreetInsider
Form 4 PFIZER INC For: Aug 05 Filed by: DAMICO JENNIFER B.
August 6, 2026 11:27 AM - SEC Filing
Form 4 PFIZER INC For: Aug 05 Filed by: BLAYLOCK RONALD E
August 5, 2026 4:05 PM - SEC Filing
Form 4 PFIZER INC For: Aug 05 Filed by: Buckley Mortimer J
August 5, 2026 4:03 PM - SEC Filing
Form 10-Q PFIZER INC For: Jun 28
August 4, 2026 7:05 AM - SEC Filing
Form 8-K PFIZER INC For: Aug 04
August 4, 2026 7:03 AM - SEC Filing
Pfizer (PFE) Tops Q2 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
August 4, 2026 6:47 AM - StreetInsider
Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance
August 4, 2026 6:45 AM - BizWire
Pfizer Q2 earnings preview: Analysts eye pipeline updates, portfolio resilience
August 3, 2026 11:30 PM - StreetInsider
Form 4 PFIZER INC For: Jul 31 Filed by: BOURLA ALBERT
August 3, 2026 7:51 PM - SEC Filing
Pfizer (PFE) call put ratio 1.1 calls to 1 put into quarter results
August 3, 2026 10:54 AM - StreetInsider
Pfizer (PFE) call put ratio 1.9 calls to 1 put into quarter results
August 3, 2026 6:02 AM - StreetInsider
U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
August 1, 2026 10:00 AM - StreetInsider
Pfizer's Litfulo meets Phase 3 goals in vitiligo skin condition
July 30, 2026 6:45 AM - StreetInsider
Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo
July 30, 2026 6:45 AM - BizWire
FDA grants priority review for Pfizer's Talzenna and Xtandi combo in prostate cancer
July 22, 2026 4:30 PM - StreetInsider
FDA Grants Priority Review for Pfizer’s TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer
July 22, 2026 4:30 PM - BizWire
Form 4 PFIZER INC For: Jul 15 Filed by: BOURLA ALBERT
July 16, 2026 6:18 PM - SEC Filing
Pfizer temporarily discontinues premarin vaginal cream in India, citing supply challenges - Reuters
July 16, 2026 1:35 PM - StreetInsider
Form 4 PFIZER INC For: Jul 09 Filed by: BOURLA ALBERT
July 13, 2026 3:43 PM - SEC Filing
Pfizer (PFE) PT Lowered to $30 at BMO Capital
July 13, 2026 7:37 AM - StreetInsider
Pfizer (PFE) PT Lowered to $35 at Guggenheim
July 13, 2026 6:51 AM - StreetInsider
FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer
July 10, 2026 11:23 AM - StreetInsider
U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
July 10, 2026 11:23 AM - BizWire
Pfizer (PFE) PT Lowered to $28 at JPMorgan
July 8, 2026 7:05 AM - StreetInsider
HSBC Downgrades Pfizer (PFE) to Hold
July 6, 2026 1:35 AM - StreetInsider
Form 4 PFIZER INC For: Jun 30 Filed by: BOURLA ALBERT
July 1, 2026 3:50 PM - SEC Filing
Form 4 PFIZER INC For: Jun 26 Filed by: Buckley Mortimer J
June 30, 2026 3:19 PM - SEC Filing
Form 4 PFIZER INC For: Jun 26 Filed by: Echevarria Joseph
June 30, 2026 3:19 PM - SEC Filing
Form 4 PFIZER INC For: Jun 26 Filed by: NARAYEN SHANTANU
June 30, 2026 3:17 PM - SEC Filing
Form 4 PFIZER INC For: Jun 26 Filed by: SMITH JAMES C
June 30, 2026 3:11 PM - SEC Filing
Form 4 PFIZER INC For: Jun 26 Filed by: Quincey James
June 30, 2026 3:10 PM - SEC Filing
Form 4 PFIZER INC For: Jun 26 Filed by: Taraporevala Cyrus
June 30, 2026 3:09 PM - SEC Filing
Pfizer (PFE) Declares $0.43 Quarterly Dividend; 7.1% Yield
June 24, 2026 3:52 PM - StreetInsider
Pfizer Declares Third-Quarter 2026 Dividend
June 24, 2026 3:52 PM - BizWire
FDA approves Pfizer's Ibrance for HR+, HER2+ metastatic breast cancer
June 24, 2026 2:10 PM - StreetInsider
FDA Approves Pfizer’s IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance
June 24, 2026 2:10 PM - BizWire
FDA: approves Pfizer's palbociclib (ibrance) with trastuzumab for HR-positive, her2-positive metastatic breast cancer
June 24, 2026 11:42 AM - StreetInsider
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
June 24, 2026 8:30 AM - StreetInsider
Enanta Pharma loses appeal in Pfizer Paxlovid patent case
June 23, 2026 5:30 PM - StreetInsider
Pfizer executive says China now leads Europe in drug innovation
June 23, 2026 12:15 PM - StreetInsider
Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts
June 23, 2026 10:00 AM - BizWire
BMO Capital on Pfizer (PFE): 'SigVie Trial Misses on OS With Signs of Benefit for Future Trials'
June 23, 2026 8:44 AM - StreetInsider
Pfizer (PFE) Reiterated at Neutral by Cantor Fitzgerald on Negative SV Data
June 23, 2026 7:24 AM - StreetInsider
Pfizer lung cancer drug misses survival goal in Phase 3 trial
June 22, 2026 4:30 PM - StreetInsider
Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
June 22, 2026 4:30 PM - BizWire
Pfizer reafffirms 2026 guidance after CFO transition announcement
June 18, 2026 1:24 PM - StreetInsider
Pfizer reaffirms 2026 guidance after CFO transition news
June 18, 2026 1:18 PM - StreetInsider
Form 8-K PFIZER INC For: Jun 18
June 18, 2026 1:17 PM - SEC Filing
FreeCast surges premarket; Accenture, Novocure slide
June 18, 2026 8:02 AM - StreetInsider
Form 8-K PFIZER INC For: Jun 18
June 18, 2026 7:07 AM - SEC Filing
Pfizer CFO Dave Denton to leave for consumer goods role
June 18, 2026 6:45 AM - StreetInsider
Pfizer Announces Chief Financial Officer Transition
June 18, 2026 6:45 AM - BizWire
Arvinas and Pfizer complete Rigel license deal for vepdegestrant
June 16, 2026 4:33 PM - StreetInsider
Form 4 PFIZER INC For: Jun 15 Filed by: BOURLA ALBERT
June 16, 2026 4:21 PM - SEC Filing
Form 11-K PFIZER INC For: Dec 31
June 16, 2026 4:02 PM - SEC Filing
Form 11-K PFIZER INC For: Dec 31
June 16, 2026 3:49 PM - SEC Filing
German government to drop variable drug discounting plans - Reuters
June 15, 2026 6:08 AM - StreetInsider
Form 4 PFIZER INC For: Jun 09 Filed by: DAMICO JENNIFER B.
June 10, 2026 7:58 PM - SEC Filing
Pfizer upgraded by RBC as valuation resets ahead of key pipeline catalysts
June 10, 2026 3:50 PM - StreetInsider
RBC Capital Upgrades Pfizer (PFE) to Sector Perform
June 10, 2026 2:29 AM - StreetInsider
Cancer's Toughest Targets Are Drawing Wall Street's Attention as Oncology Innovation Accelerates
June 9, 2026 9:44 AM - StreetInsider
FDA approves expanded HYMPAVZI use for hemophilia patients with inhibitors
June 8, 2026 6:45 AM - StreetInsider
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need
June 8, 2026 6:45 AM - BizWire
Full Article List
